期刊
NATURE REVIEWS DRUG DISCOVERY
卷 8, 期 4, 页码 297-307出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrd2356
关键词
-
资金
- National Institutes of Health [AI-055509, MH-074404, AI-074564]
- Kyorin Pharmaceutical Company [1599]
- Fonds de la Recherche en Sante du Quebec
Biological barriers regulate the passage of cells, pathogens, fluids, nutrients, ions and signalling molecules between anatomical compartments during homeostasis and disease. Yet strategies that allow for reversible therapeutic modulation of these barriers are still in their infancy. The enhancement or protection of natural barriers is desirable in conditions such as acute respiratory distress syndrome or ischaemia-reperfusion injuries, whereas a temporary disruption could facilitate the penetration of drugs across such barriers. This Review discusses the role of sphingosine-1-phosphate receptors in the regulation and protection of biological barriers, and the potential of therapeutic strategies that target this receptor family.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据